Company · CIK 1756594
Inventiva S.A.
| CIK | 1756594 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | I0 |
| Business address | France |
| Listed | IVA (Nasdaq), IVEVF (OTC) |
| First annual or quarterly report | 2021-03-15 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-290863 | 2025-10-14 | 2025-11-13 | 3 | |
| 333-258369 | 2021-08-02 | 2023-09-28 | 3 | |
| 333-239312 | 2020-06-19 | 2020-07-13 | 5 |
Filings
13| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-06-02 | 424B5Shelf takedown | 333-296414 | 0001104659-26-069493 |
| 2025-11-13 | 424B5Shelf takedown | 333-290863 | 0001104659-25-111403 |
| 2025-11-12 | 424B5Shelf takedown | 333-290863 | 0001104659-25-110422 |
| 2025-10-14 | F-3Shelf registered | 333-290863 | 0001104659-25-099260 |
| 2023-09-28 | 424B5Shelf takedown | 333-258369 | 0001104659-23-104830 |
| 2021-08-06 | EFFECTDeclared effective | 333-258369 | 9999999995-21-003097 |
| 2021-08-02 | F-3Shelf registered | 333-258369 | 0001104659-21-098910 |
| 2020-07-13 | 424B4Final prospectus | 333-239312 | 0001047469-20-004078 |
| 2020-07-09 | EFFECTDeclared effective | 333-239312 | 9999999995-20-001740 |
| 2020-07-08 | F-1/AAmendment | 333-239312 | 0001047469-20-004039 |
| 2020-07-06 | F-1/AAmendment | 333-239312 | 0001047469-20-003979 |
| 2020-06-19 | F-1Registration filed | 333-239312 | 0001047469-20-003738 |
| 2020-04-10 | DRSDraft made public | 377-03119 | 0000912057-20-000122 |